Different immunological mechanisms govern protection from experimental stroke in young and older mice with recombinant TCR ligand therapy

Stroke is a leading cause of death and disability in the United States. The lack of clinical success in stroke therapies can be attributed, in part, to inadequate basic research on aging rodents. The current study demonstrates that recombinant TCR ligand therapy uses different immunological mechanis...

Descripción completa

Detalles Bibliográficos
Autores principales: Dotson, Abby L., Zhu, Wenbin, Libal, Nicole, Alkayed, Nabil J., Offner, Halina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174768/
https://www.ncbi.nlm.nih.gov/pubmed/25309326
http://dx.doi.org/10.3389/fncel.2014.00284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174768/
https://www.ncbi.nlm.nih.gov/pubmed/25309326
http://dx.doi.org/10.3389/fncel.2014.00284

Ejemplares similares